Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biomarkers for immunotherapy response in head and neck cancer.
Gavrielatou N, Doumas S, Economopoulou P, Foukas PG, Psyrri A. Gavrielatou N, et al. Among authors: foukas pg. Cancer Treat Rev. 2020 Mar;84:101977. doi: 10.1016/j.ctrv.2020.101977. Epub 2020 Jan 24. Cancer Treat Rev. 2020. PMID: 32018128 Review.
Expression analysis of proteins involved in the non homologous end joining DNA repair mechanism, in the bone marrow of adult de novo myelodysplastic syndromes.
Economopoulou P, Pappa V, Kontsioti F, Papageorgiou S, Foukas P, Liakata E, Economopoulou C, Vassilatou D, Ioannidou ED, Chondropoulos S, Tsirigotis P, Papageorgiou E, Dervenoulas J, Economopoulos T. Economopoulou P, et al. Ann Hematol. 2010 Mar;89(3):233-9. doi: 10.1007/s00277-009-0823-6. Epub 2009 Sep 2. Ann Hematol. 2010. PMID: 19727724
Increased expression of phosphorylated NBS1, a key molecule of the DNA damage response machinery, is an adverse prognostic factor in patients with de novo myelodysplastic syndromes.
Kefala M, Papageorgiou SG, Kontos CK, Economopoulou P, Tsanas A, Pappa V, Panayiotides IG, Gorgoulis VG, Patsouris E, Foukas PG. Kefala M, et al. Among authors: foukas pg. Leuk Res. 2013 Nov;37(11):1576-82. doi: 10.1016/j.leukres.2013.08.018. Epub 2013 Sep 5. Leuk Res. 2013. PMID: 24054861
Novel technologies and emerging biomarkers for personalized cancer immunotherapy.
Yuan J, Hegde PS, Clynes R, Foukas PG, Harari A, Kleen TO, Kvistborg P, Maccalli C, Maecker HT, Page DB, Robins H, Song W, Stack EC, Wang E, Whiteside TL, Zhao Y, Zwierzina H, Butterfield LH, Fox BA. Yuan J, et al. Among authors: foukas pg. J Immunother Cancer. 2016 Jan 19;4:3. doi: 10.1186/s40425-016-0107-3. eCollection 2016. J Immunother Cancer. 2016. PMID: 26788324 Free PMC article. Review.
Investigation of prognostic biomarkers in patients with urothelial carcinoma treated with platinum-based regimens.
Papadopoulou K, Koliou GA, Tsimiliotis D, Kotoula V, Foukas P, Goussia A, Tsiatas M, Visvikis A, Chatzopoulos K, Nifora M, Charchanti A, Koumarianou A, Christodoulou C, Pectasides D, Psyrri A, Fostira F, Fountzilas G, Samantas E. Papadopoulou K, et al. Urol Oncol. 2022 Dec;40(12):538.e15-538.e24. doi: 10.1016/j.urolonc.2022.07.007. Epub 2022 Aug 28. Urol Oncol. 2022. PMID: 36041976
Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC).
Economopoulou P, Spathis A, Kotsantis I, Maratou E, Anastasiou M, Moutafi MK, Kirkasiadou M, Pantazopoulos A, Giannakakou M, Edelstein DL, Sloane H, Fredebohm J, Jones FS, Kyriazoglou A, Gavrielatou N, Foukas P, Panayiotides I, Psyrri A. Economopoulou P, et al. Oral Oncol. 2023 Apr;139:106358. doi: 10.1016/j.oraloncology.2023.106358. Epub 2023 Mar 3. Oral Oncol. 2023. PMID: 36871349
Digital Spatial Profiling Links Beta-2-microglobulin Expression with Immune Checkpoint Blockade Outcomes in Head and Neck Squamous Cell Carcinoma.
Gavrielatou N, Vathiotis I, Aung TN, Shafi S, Burela S, Fernandez AI, Moutafi M, Burtness B, Economopoulou P, Anastasiou M, Foukas P, Psyrri A, Rimm DL. Gavrielatou N, et al. Cancer Res Commun. 2023 Apr 11;3(4):558-563. doi: 10.1158/2767-9764.CRC-22-0299. eCollection 2023 Apr. Cancer Res Commun. 2023. PMID: 37057033 Free PMC article.
Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer.
Moutafi M, Koliou GA, Papaxoinis G, Economopoulou P, Kotsantis I, Gkotzamanidou M, Anastasiou M, Pectasides D, Kyrodimos E, Delides A, Giotakis E, Papadimitriou NG, Panayiotides IG, Perisanidis C, Fernandez AI, Xirou V, Poulios C, Gagari E, Yaghoobi V, Gavrielatou N, Shafi S, Aung TN, Kougioumtzopoulou A, Kouloulias V, Palialexis K, Gkolfinopoulos S, Strati A, Lianidou E, Fountzilas G, Rimm DL, Foukas PG, Psyrri A. Moutafi M, et al. Among authors: foukas pg. Cancer Res Commun. 2023 Aug 10;3(8):1514-1523. doi: 10.1158/2767-9764.CRC-23-0051. eCollection 2023 Aug. Cancer Res Commun. 2023. PMID: 37575280 Free PMC article. Clinical Trial.
92 results